170 related articles for article (PubMed ID: 15639067)
1. Comparison of misoprostol plasma concentrations following buccal and sublingual administration.
Schaff EA; DiCenzo R; Fielding SL
Contraception; 2005 Jan; 71(1):22-5. PubMed ID: 15639067
[TBL] [Abstract][Full Text] [Related]
2. A crossover pharmacokinetic study of misoprostol by the oral, sublingual and buccal routes.
Frye LJ; Byrne ME; Winikoff B
Eur J Contracept Reprod Health Care; 2016 Aug; 21(4):265-8. PubMed ID: 27102981
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of repeated doses of misoprostol.
Tang OS; Schweer H; Lee SW; Ho PC
Hum Reprod; 2009 Aug; 24(8):1862-9. PubMed ID: 19395364
[TBL] [Abstract][Full Text] [Related]
4. Misoprostol administered by epithelial routes: Drug absorption and uterine response.
Meckstroth KR; Whitaker AK; Bertisch S; Goldberg AB; Darney PD
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):582-90. PubMed ID: 16946218
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic profiles up to 12 h after administration of vaginal, sublingual and slow-release oral misoprostol.
Aronsson A; Fiala C; Stephansson O; Granath F; Watzer B; Schweer H; Gemzell-Danielsson K
Hum Reprod; 2007 Jul; 22(7):1912-8. PubMed ID: 17488782
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics and different regimens of misoprostol in early first-trimester medical abortion.
Tang OS; Ho PC
Contraception; 2006 Jul; 74(1):26-30. PubMed ID: 16781256
[TBL] [Abstract][Full Text] [Related]
7. A randomised comparative study on sublingual versus vaginal administration of misoprostol for termination of pregnancy between 13 to 20 weeks.
Bhattacharjee N; Saha SP; Ghoshroy SC; Bhowmik S; Barui G
Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):165-71. PubMed ID: 18366490
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of mifepristone and buccal or vaginal misoprostol for abortion through 56 days of last menstrual period.
Middleton T; Schaff E; Fielding SL; Scahill M; Shannon C; Westheimer E; Wilkinson T; Winikoff B
Contraception; 2005 Nov; 72(5):328-32. PubMed ID: 16246656
[TBL] [Abstract][Full Text] [Related]
10. Comparing vaginal and buccal misoprostol when used after methotrexate for early abortion.
Wiebe ER; Trouton K
Contraception; 2004 Dec; 70(6):463-6. PubMed ID: 15541407
[TBL] [Abstract][Full Text] [Related]
11. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
Hamoda H; Ashok PW; Flett GM; Templeton A
BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of different routes of administration of misoprostol.
Tang OS; Schweer H; Seyberth HW; Lee SW; Ho PC
Hum Reprod; 2002 Feb; 17(2):332-6. PubMed ID: 11821273
[TBL] [Abstract][Full Text] [Related]
13. Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial.
Diop A; Raghavan S; Rakotovao JP; Comendant R; Blumenthal PD; Winikoff B
Contraception; 2009 Jun; 79(6):456-62. PubMed ID: 19442782
[TBL] [Abstract][Full Text] [Related]
14. Sublingual versus vaginal misoprostol (400 microg) for cervical priming in first-trimester abortion: a randomized trial.
Carbonell Esteve JL; Marí JM; Valero F; Llorente M; Salvador I; Varela L; Leal P; Candel A; Tudela A; Serrano M; Muñoz E
Contraception; 2006 Oct; 74(4):328-33. PubMed ID: 16982235
[TBL] [Abstract][Full Text] [Related]
15. Sublingual compared with oral misoprostol for cervical dilatation prior to vacuum aspiration: a randomized comparison.
Aronsson A; Helström L; Gemzell-Danielsson K
Contraception; 2004 Feb; 69(2):165-9. PubMed ID: 14759623
[TBL] [Abstract][Full Text] [Related]
16. Sublingual versus vaginal misoprostol for cervical ripening PRIOR TO manual vacuum aspiration under local anaesthesia: a randomized study.
Caliskan E; Filiz T; Yucesoy G; Coskun E; Vural B; Corakci A
Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):372-7. PubMed ID: 17853158
[TBL] [Abstract][Full Text] [Related]
17. A randomised comparison between sublingual, oral and vaginal route of misoprostol for pre-abortion cervical ripening in first-trimester pregnancy termination under local anaesthesia.
Saxena P; Sarda N; Salhan S; Nandan D
Aust N Z J Obstet Gynaecol; 2008 Feb; 48(1):101-6. PubMed ID: 18275580
[TBL] [Abstract][Full Text] [Related]
18. Absorption kinetics of misoprostol with oral or vaginal administration.
Zieman M; Fong SK; Benowitz NL; Banskter D; Darney PD
Obstet Gynecol; 1997 Jul; 90(1):88-92. PubMed ID: 9207820
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of a novel oral slow-release form of misoprostol.
Fiala C; Aronsson A; Granath F; Stephansson O; Seyberth HW; Watzer B; Gemzell-Danielsson K
Hum Reprod; 2005 Dec; 20(12):3414-8. PubMed ID: 16055461
[TBL] [Abstract][Full Text] [Related]
20. Effect of bacterial vaginosis on the pharmacokinetics of misoprostol in early pregnancy.
Sioutas A; Sandström A; Fiala C; Watzer B; Schweer H; Gemzell-Danielsson K
Hum Reprod; 2012 Feb; 27(2):388-93. PubMed ID: 22128294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
